Company intelligence / Profile preview
VaxThera
Rionegro, Antioquia, Colombiavaxthera.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
VaxThera reports a universal SARS-CoV-2 vaccine in preclinical studies (originally in Wisconsin) and has obtained at least one patent for a vaccine designed to protect against multiple Covid-19 variants and Mpox; as of 2024–2025, its new 35,000 m² facility near Medellín/Rionegro is being brought through INVIMA certification for commercial-scale manufacturing, but no VaxThera-originated products are yet reported as in human clinical trials.[1][5][7]
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccinemRNA-based drugsViral vectorBiologic
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Partnerships
Ministry of Health of Colombia[5]National Institute of Health of Colombia (Instituto Nacional de Salud)[5]European Investment Bank (project financing partner)[6]Forward Bio Labs (R&D collaboration site in Madison, Wisconsin)[3]Academic and industrial partners in Brazil and Argentina for vaccine research networks[5]
Beyond the preview
Go deeper on VaxThera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VaxThera.